122. Superficial siderosis
3 clinical trials, 7 drugs (DrugBank: 2 drugs), 0 gene, 0 pathway
Searched query = "Superficial siderosis", "Brain table hemosiderosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000021218 | 2024/09/30 | 26/02/2016 | An efficacy of iron chelator to superficial siderosis | An efficacy of iron chelator to superficial siderosis - EICHSS | superficial siderosis of CNS | deferiprone | Department of Neurology, Tokyo Medical and Dental University | NULL | Recruiting | 20years-old | Not applicable | Male and Female | 5 | Not applicable | Japan |
| 2 | NCT04200664 (ClinicalTrials.gov) | February 7, 2020 | 10/12/2019 | Audiovestibular Function in Infratentorial Superficial Siderosis | Clinical and Imaging Biomarkers of Audiovestibular Function in Infratentorial Superficial Siderosis | Siderosis;Neurological Disorder;Rare Diseases;Age Related Hearing Loss;Presbycusis | Diagnostic Test: Hearing assessment;Diagnostic Test: Vestibular/balance assessment;Other: Quality of life assessment;Diagnostic Test: Olfactory (smell) function testing;Genetic: DNA bio-banking | University College, London | NIHR UCLH BRC;The Bernice Bibby Research Trust | Recruiting | 18 Years | N/A | All | 90 | United Kingdom | |
| 3 | JPRN-jRCTs031180438 | 01/04/2019 | 27/03/2019 | Evaluation of iron chelator administration, and cochlear implantation for superficial siderosis | Evaluation of iron chelator administration, and cochlear implantation for superficial siderosis - ECHACISS | Superficial siderosis siderosis, cerebellar ataxia, hearing loss, superficial siderosis | 1. Administration of Deferiprone orally 30mg/kg after every meal for 36 months. 2. Artificial cochlear implantation for severe hearing disturbance | Sanjo Nobuo | NULL | Recruiting | >= 20age old | Not applicable | Both | 50 | N/A | Japan |